Candel Therapeutics, Inc. (CADL) Reports Q2 Loss of $0.74/sh
Go back to Candel Therapeutics, Inc. (CADL) Reports Q2 Loss of $0.74/sh| (NASDAQ: CADL) | Delayed: 9.08 -0.07 (0.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.15 | 52 Week High | $ | |||
| Open | $8.96 | 52 Week Low | $ | |||
| Day High | $9.32 | P/E | N/A | |||
| Day Low | $8.96 | EPS | $ | |||
| Volume | 992,654 | |||||

